Activated protein C resistance phenotype in patients with antiphospholipid antibodies-Reference-Cited by-同舟云学术

Activated protein C resistance phenotype in patients with antiphospholipid antibodies

Published:1997-08 Issue:2 Volume:130 Page:202-208
ISSN:0022-2143
Container-title:Journal of Laboratory and Clinical Medicine
language:en
Short-container-title:Journal of Laboratory and Clinical Medicine

Author:

Aznar Justo,Villa Piedad,España Francisco,Estellés Amparo,Grancha Salvador,Falcó Cristina

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference44 articles.

1. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C;Dahlbäck,1993

2. Mutation in blood coagulation factor V associated with resistance to activated protein C;Bertina;Nature,1994

3. Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C;Zoller;J Clin Invest,1994

4. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis;Zoller;Lancet,1994

5. Inherited thrombophilia: resistance to activated protein CI as pathogenic factor of venous thromboembolism;Dahlback;Blood,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of the protein C pathway abnormality‐related thrombophilia by using thrombomodulin‐mediated tissue factor‐triggered clot waveform analysis;European Journal of Haematology;2022-05-04

2. Activated Protein C Resistance and Antiphospholipid Antibodies in Recurrent Fetal Loss: Experience of a Single Referral Center in Northern Iraq;Indian Journal of Hematology and Blood Transfusion;2014-02-23

3. Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice;BMC Medicine;2013-04-04

4. Thrombosis in Systemic Lupus Erythematosus: A Review Article;ISRN Rheumatology;2012-07-30

5. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study;Thrombosis Research;2009-05